The Federal Trade Commission (FTC) has intervened to halt a significant healthcare deal in California. The FTC has taken issue with the proposed acquisition by nonprofit John Muir Health of Tenet Healthcare’s majority stake in San Ramon Regional Medical Center for $142.5 million.
John Muir Health, which has held a 49% interest in San Ramon Regional Medical Center since 2013, had revealed plans earlier in the year to acquire full ownership and operational control of the 123-bed facility. However, the FTC contends that this consolidation would lead to decreased competition and higher healthcare costs for consumers in the I-680 corridor of California.
According to the FTC’s release, the primary competitors for inpatient general acute care in the relevant area are two other hospitals operated by John Muir Health. If the deal were to proceed, the FTC argues that the Walnut Creek-based healthcare system would control over 50% of the market, raising concerns about monopolistic practices.
Related: FTC Sues To Stop Hospital Merger
“San Ramon Regional Medical Center has played an important role in ensuring Californians in the I-680 corridor have access to quality, affordable care for critical health care services, such as cardiac surgery and childbirth,” stated Henry Liu, Director of the FTC’s Bureau of Competition. “John Muir’s acquisition of San Ramon Medical would increase already high health care costs in the area and threaten to stall quality improvements that help advance care for all patients.”
According to Fierce Pharma, the FTC has taken decisive action by issuing an administrative complaint and authorizing a lawsuit to be filed in the U.S. District Court for the Northern District of California. The regulatory body is seeking a temporary restraining order and preliminary injunction to prevent the completion of the proposed transaction. The decision to pursue legal action was made in a unanimous 3-0 vote by the FTC’s commissioners.
Throughout its investigation, the FTC collaborated closely with the California attorney general’s office, and the latter is expected to join the court filing. The regulatory body alleges that the proposed deal would result in higher insurance premiums, co-pays, deductibles, and other out-of-pocket costs, or reduced benefits for commercial health insurance enrollees.
Source: Fierce Healthcare
Featured News
Google and South Carolina Clash Over State Records Demand
May 8, 2024 by
CPI
Telefonica Germany Teams Up with Amazon Web Services to Migrate 5G Customers
May 8, 2024 by
CPI
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI